The UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to address competition concerns that the regulator has been investigating.

Vifor Pharma has pledged to pay £23 million to the NHS after Britain’s competition watchdog raised concerns the drugs firm had been making misleading claims about the safety of a rival’s iron ...

Vifor Pharma has agreed to pay £23m to the NHS after being accused by Britain's competition watchdog of making false safety claims about a competitor's iron deficiency treatment. The Competition ...

Vifor Pharma has pledged to pay £23 million to the NHS after Britain’s competition watchdog raised concerns over misleading claims (Jeff Moore/PA) Vifor Pharma has pledged to pay £23 million ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Vifor Pharma has pledged to pay £23 million to the NHS after Britain’s competition watchdog raised concerns the drugs firm had been making misleading claims about the safety of a rival’s iron ...